Translational Research
Volume 155, Issue 4 , Pages 157-163, April 2010

Health-related quality of life in Hispanics with chronic kidney disease

  • Anna C. Porter

      Affiliations

    • Section of Nephrology, University of Illinois at Chicago, Chicago, Ill
    • Corresponding Author InformationReprint requests: Anna C. Porter, MD, Section of Nephrology (MC 793), University of Illinois at Chicago, 820 South Wood Street, Room 417W, Chicago, IL 60612
    • ,
  • Julio C. Vijil Jr.

      Affiliations

    • Section of Nephrology, University of Illinois at Chicago, Chicago, Ill
    • ,
  • Mark Unruh

      Affiliations

    • Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, Pa
    • ,
  • Claudia Lora

      Affiliations

    • Section of Nephrology, University of Illinois at Chicago, Chicago, Ill
    • ,
  • James P. Lash

      Affiliations

    • Section of Nephrology, University of Illinois at Chicago, Chicago, Ill

Received 5 October 2009; accepted 20 October 2009. published online 16 November 2009.

Health-related quality of life (HRQOL) is an important patient-reported outcome that has gained attention in research and clinical practice. In recent years, reports of chronic kidney disease (CKD) have increased. However, not much information is available for Hispanics with CKD, a group whose rates of incidents are on the rise. This review discusses the measurement of HRQOL in CKD, with a particular focus on issues pertaining to Hispanics. Future research directions also are discussed.

Abbreviations: CKD, chronic kidney disease, DOPPS, dialysis outcomes and practice pattern study, ESRD, end-stage renal disease, HRQOL, health-related quality of life, KDC, Kidney Disease Composite, KDQOL, Kidney Disease Quality of Life, KDQOL-SF, Kidney Disease Quality of Life Short Form, MHC, Mental Health Composite, PHC, Physical Health Composite, SF-36, Short Form-36

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Anna Porter, MD, is a Research Renal Fellow, Section of Nephrology, University of Illinois at Chicago. Her article is based on a presentation given at the Combined Annual Meeting of the Central Society for Clinical Research and Midwestern Section American Federation for Medical Research held in Chicago, Ill, April 2008.

 Supported by Grant K08DK079671-01 from the National Institutes of Health.

PII: S1931-5244(09)00322-3

doi:10.1016/j.trsl.2009.10.005

Translational Research
Volume 155, Issue 4 , Pages 157-163, April 2010

Article Tools